The	O
Yellow	other-disease
Fever	other-disease
in	O
Buenos	location-GPE
Aires	location-GPE
was	O
a	O
series	O
of	O
epidemics	O
that	O
took	O
place	O
in	O
1852	O
,	O
1858	O
,	O
1870	O
and	O
1871	O
,	O
the	O
latter	O
being	O
a	O
disaster	O
that	O
killed	O
about	O
8	O
%	O
of	O
Porteños	location-GPE
:	O
in	O
a	O
city	O
where	O
the	O
daily	O
death	O
rate	O
was	O
less	O
than	O
20	O
,	O
there	O
were	O
days	O
that	O
killed	O
more	O
than	O
500	O
people	O
.	O

Levodopa	other-biologything
has	O
been	O
reported	O
to	O
improve	O
symptoms	O
in	O
patients	O
with	O
Parkinson	other-disease
’	other-disease
s	other-disease
disease	other-disease
and	O
progressive	O
supranuclear	other-disease
palsy	other-disease
.	O

A	O
genetic	O
disorder	O
causing	O
multiple	other-disease
cysts	other-disease
to	O
form	O
in	O
the	O
liver	O
tissue	O
,	O
usually	O
in	O
later	O
life	O
,	O
and	O
usually	O
asymptomatic	O
,	O
is	O
polycystic	O
liver	O
disease	O
.	O

The	O
incidence	O
of	O
PAIS	other-disease
is	O
estimated	O
to	O
be	O
one	O
in	O
130,000	O
.	O

He	O
discovered	O
that	O
in	O
the	O
direct	O
radiograms	O
and	O
in	O
the	O
urographic	O
images	O
,	O
you	O
can	O
identify	O
determining	O
elements	O
for	O
a	O
differential	O
diagnosis	O
with	O
the	O
Wilms	other-disease
'	other-disease
tumor	other-disease
.	O

Neurodegeneration	other-disease
is	O
the	O
progressive	O
loss	O
of	O
structure	O
or	O
function	O
of	O
neurons	other-biologything
,	O
including	O
their	O
death	O
.	O

virus	O
infection	O
may	O
be	O
either	O
acute	O
(	O
self-limiting	other-disease
)	O
or	O
chronic	O
(	O
long-standing	O
)	O
.	O

There	O
is	O
no	O
cure	O
for	O
Gerstmann	other-disease
syndrome	O
.	O

As	O
a	O
survivor	O
of	O
viral	other-disease
meningitis	other-disease
,	O
she	O
felt	O
a	O
need	O
to	O
spread	O
awareness	O
of	O
the	O
disease	O
.	O

HLA-B15	other-disease
allele	other-disease
*	other-disease
1502	other-disease
is	O
associated	O
with	O
the	O
severe	O
skin	O
conditions	O
Stevens–Johnson	other-disease
syndrome	other-disease
(	O
SJS	other-disease
)	O
and	O
toxic	other-disease
epidermal	other-disease
necrolysis	other-disease
(	O
TEN	other-disease
)	O
caused	O
by	O
carbamazepine	O
drug	O
sensitivity	O
in	O
East	O
Asians	location-GPE
.	O

Many	O
people	O
with	O
CF	other-disease
use	O
probiotics	O
,	O
which	O
are	O
thought	O
to	O
be	O
able	O
to	O
correct	O
intestinal	O
dysbiosis	O
and	O
inflammation	O
,	O
but	O
the	O
clinical	O
trial	O
evidence	O
regarding	O
the	O
effectiveness	O
of	O
probiotics	O
for	O
reducing	O
pulmonary	O
exacerbations	O
in	O
people	O
with	O
CF	other-disease
is	O
uncertain	O
.	O

Infertile	other-disease
women	O
are	O
at	O
a	O
higher	O
risk	O
of	O
developing	O
ovarian	other-disease
cancer	other-disease
and	O
endometrial	other-disease
cancer	other-disease
when	O
compared	O
to	O
fertile	O
women	O
.	O

Acute	other-disease
ischemic	other-disease
stroke	other-disease
is	O
a	O
neurologic	O
emergency	O
that	O
may	O
be	O
reversible	O
if	O
treated	O
rapidly	O
.	O

Symptoms	O
of	O
hypokalemia	other-disease
include	O
fatigue	O
,	O
muscular	O
weakness	O
,	O
and	O
increased	O
urine	O
production	O
.	O

Proteinuria	O
is	O
usually	O
the	O
first	O
sign	O
of	O
kidney	O
involvement	O
and	O
either	O
rapidly	O
or	O
years	O
after	O
suffering	O
from	O
asymptomatic	O
deposition	O
of	O
protein	other-biologything
in	O
the	O
urine	O
,	O
kidney	O
failure	O
occurs	O
in	O
around	O
5	O
%	O
of	O
NPS	other-disease
patients	O
.	O

Discontinuation	O
of	O
heparin	other-biologything
is	O
critical	O
in	O
a	O
case	O
of	O
heparin-induced	other-disease
thrombocytopenia	other-disease
(	O
HIT	other-disease
)	O
.	O

Neuropathic	other-disease
itch	other-disease
can	O
originate	O
at	O
any	O
point	O
along	O
the	O
afferent	O
pathway	O
as	O
a	O
result	O
of	O
damage	O
of	O
the	O
nervous	O
system	O
.	O

James	person-other
Paget	person-other
first	O
proposed	O
the	O
idea	O
of	O
venous	O
thrombosis	O
causing	O
upper	O
extremity	O
pain	O
and	O
swelling	O
,	O
and	O
Leopold	person-other
von	person-other
Schrötter	person-other
later	O
linked	O
the	O
clinical	O
syndrome	O
to	O
thrombosis	O
of	O
the	O
axillary	O
and	O
subclavian	other-disease
veins	other-disease
.	O

Pulmonary	O
arterial	O
hypertension	O
occurs	O
by	O
two	O
mechanisms	O
in	O
cardiac	other-disease
sarcoidosis	other-disease
:	O
reduced	O
left	O
heart	O
function	O
due	O
to	O
granulomas	O
weakening	O
the	O
heart	O
muscle	O
or	O
from	O
impaired	O
blood	O
flow	O
.	O

In	O
the	O
2016-2017	O
outbreak	O
,	O
a	O
third	O
dose	O
of	O
the	O
MMR	other-disease
vaccine	O
was	O
given	O
to	O
college	O
students	O
who	O
had	O
a	O
previous	O
history	O
of	O
vaccination	O
.	O

The	O
surveillance	O
system	O
detects	O
,	O
alerts	O
,	O
and	O
predicts	O
future	O
regional	O
and	O
national	O
epidemics	O
specifically	O
for	O
influenza	other-disease
,	O
gastroenteritis	other-disease
and	O
Varicella	other-disease
zoster	other-disease
.	O

Severe	O
bite	O
from	O
larger	O
species	O
may	O
cause	O
a	O
dangerous	O
and	O
life-threatening	O
anaphylaxis	other-disease
if	O
not	O
treated	O
.	O

There	O
are	O
mainly	O
three	O
types	O
of	O
anterior	other-disease
pituitary	other-disease
tumors	other-disease
and	O
their	O
associated	O
disorders	O
.	O

In	O
February	O
2008	O
,	O
Erie	location-GPE
County	location-GPE
experienced	O
a	O
potential	O
Hepatitis	other-disease
A	other-disease
emergency	O
when	O
an	O
infected	O
employee	O
handled	O
produce	O
at	O
a	O
popular	O
supermarket	O
.	O

Most	O
patients	O
will	O
not	O
exhibit	O
all	O
of	O
these	O
symptoms	O
,	O
but	O
more	O
than	O
one	O
of	O
these	O
symptoms	O
will	O
be	O
present	O
in	O
a	O
patient	O
who	O
has	O
been	O
diagnosed	O
with	O
MERRF	other-disease
disease	O
.	O

The	O
most	O
common	O
cause	O
of	O
chronic	O
urinary	O
retention	O
is	O
BPH	other-disease
.	O

This	O
was	O
the	O
first	O
program	O
in	O
the	O
world	O
to	O
use	O
HIV	other-disease
positive	O
donors	O
for	O
HIV	other-disease
positive	O
recipients	O
.	O

Pulmonary	other-disease
valve	other-disease
diseases	other-disease
are	O
the	O
least	O
common	O
heart	O
valve	O
disease	O
in	O
adults	O
.	O

Long	O
term	O
use	O
of	O
tenofovir	other-chemicalthing
disoproxil	other-chemicalthing
is	O
associated	O
with	O
nephrotoxicity	other-disease
and	O
bone	O
loss	O
.	O

``	O
He	O
first	O
advanced	O
the	O
term	O
schizophrenia	other-disease
in	O
1908	O
in	O
a	O
paper	O
based	O
on	O
a	O
study	O
of	O
647	O
Burghölzli	O
patients	O
.	O

Dysrhythmias	O
and	O
sudden	O
cardiac	O
death	O
(	O
SCD	other-disease
)	O
was	O
shown	O
to	O
occur	O
even	O
before	O
the	O
manifestation	O
of	O
DCM	other-disease
and	O
heart	O
failure	O
symptoms	O
in	O
LMNA	other-disease
mutation	O
carriers	O
.	O

He	O
is	O
board	O
certified	O
in	O
internal	O
medicine	O
;	O
allergy	other-disease
,	O
asthma	other-disease
and	O
immunology	other-disease
;	O
and	O
diagnostic	O
laboratory	O
immunology	O
.	O

Neurodegeneration	other-disease
can	O
be	O
found	O
in	O
many	O
different	O
levels	O
of	O
neuronal	O
circuitry	O
ranging	O
from	O
molecular	O
to	O
systemic	O
.	O

About	O
30	O
percent	O
of	O
men	O
with	O
Peyronie	other-disease
's	other-disease
disease	other-disease
develop	O
fibrosis	O
in	O
other	O
elastic	O
tissues	O
of	O
the	O
body	O
,	O
such	O
as	O
on	O
the	O
hand	O
or	O
foot	O
,	O
including	O
Dupuytren	other-disease
's	other-disease
contracture	other-disease
of	O
the	O
hand	O
.	O

The	O
prevalence	O
of	O
HIV	other-disease
/	O
AIDS	other-disease
in	O
the	O
Dominican	location-GPE
Republic	location-GPE
in	O
2011	O
stood	O
at	O
approximately	O
0.7	O
%	O
,	O
which	O
is	O
relatively	O
low	O
by	O
Caribbean	location-GPE
standards	O
,	O
with	O
an	O
estimated	O
62,000	O
HIV	other-disease
/	O
AIDS	other-disease
-positive	O
Dominicans	O
.	O

This	O
effectively	O
divides	O
the	O
cataract	other-disease
into	O
four	O
quadrants	O
that	O
are	O
more	O
easily	O
removed	O
by	O
phacoemulsification	O
.	O

Schwartz	person-other
is	O
credited	O
with	O
the	O
clinical	O
description	O
of	O
new	O
subtypes	O
of	O
Kaposi	other-disease
's	other-disease
sarcoma	other-disease
:	O
telangiectatic	other-disease
Kaposi	other-disease
's	other-disease
sarcoma	other-disease
,	O
keloidal	other-disease
Kaposi	other-disease
's	other-disease
sarcoma	other-disease
and	O
ecchymotic	other-disease
Kaposi	other-disease
’	other-disease
s	other-disease
sarcoma	other-disease
.	O

Wasting	other-disease
is	O
caused	O
by	O
acute	O
malnutrition	O
.	O

It	O
is	O
classified	O
as	O
type	other-disease
II	other-disease
lupus	other-disease
nephritis	other-disease
by	O
the	O
World	organization-other
Health	organization-other
Organization	organization-other
(	O
WHO	organization-other
)	O
.	O

About	O
6	O
%	O
of	O
people	O
have	O
insomnia	other-disease
that	O
is	O
not	O
due	O
to	O
another	O
problem	O
and	O
lasts	O
for	O
more	O
than	O
a	O
month	O
.	O

The	O
long-acting	O
injectable	O
form	O
of	O
risperidone	product-other
may	O
be	O
advantageous	O
over	O
long	O
acting	O
first	O
generation	O
antipsychotics	O
,	O
as	O
it	O
is	O
better	O
tolerated	O
(	O
fewer	O
extrapyramidal	O
effects	O
)	O
and	O
because	O
long	O
acting	O
injectable	O
formulations	O
of	O
first	O
generation	O
antipsychotics	product-other
may	O
increase	O
the	O
risk	O
of	O
depression	other-disease
.	O

The	O
slightly	O
higher	O
preference	O
for	O
SSRIs	product-other
over	O
SNRIs	product-other
as	O
a	O
first	O
choice	O
for	O
treatment	O
of	O
anxiety	other-disease
disorders	other-disease
may	O
have	O
been	O
influenced	O
by	O
the	O
observation	O
of	O
poorer	O
tolerability	O
of	O
the	O
SNRIs	product-other
in	O
comparison	O
to	O
SSRIs	product-other
in	O
systematic	O
reviews	O
of	O
studies	O
of	O
depressed	O
patients	O
.	O

Both	O
of	O
these	O
entities	O
can	O
be	O
considered	O
subtypes	O
of	O
Hashimoto	other-disease
's	other-disease
thyroiditis	other-disease
and	O
have	O
an	O
autoimmune	O
basis	O
.	O

Bullous	other-disease
keratopathy	other-disease
that	O
is	O
characterized	O
by	O
corneal	O
stromal	O
edema	O
related	O
to	O
cell	O
loss	O
and	O
endothelial	O
decompensation	O
as	O
well	O
as	O
subepithelial	O
fibrosis	O
and	O
corneal	O
vascularization	O
in	O
further	O
cases	O
,	O
results	O
vision	O
problems	O
due	O
to	O
loss	O
of	O
corneal	O
transparency	O
.	O

Splenomegaly	other-disease
may	O
also	O
come	O
from	O
bacterial	O
infections	O
,	O
such	O
as	O
syphilis	other-disease
or	O
an	O
infection	O
of	O
the	O
heart	O
's	O
inner	O
lining	O
(	O
endocarditis	other-disease
)	O
.	O

Ulcerative	other-disease
colitis	other-disease
(	O
UC	other-disease
)	O
is	O
a	O
long-term	O
condition	O
that	O
results	O
in	O
inflammation	O
and	O
ulcers	O
of	O
the	O
colon	O
and	O
rectum	O
.	O

It	O
is	O
well	O
accepted	O
that	O
alternative	O
splicing	O
has	O
a	O
role	O
in	O
SZ	other-disease
pathology	O
.	O

It	O
is	O
used	O
as	O
a	O
topical	O
cream	O
against	O
fungal	O
skin	O
infections	O
,	O
including	O
``	O
Trichophyton	other-disease
mentagrophytes	other-disease
``	O
,	O
``	O
T.	other-disease
rubrum	other-disease
``	O
,	O
``	O
Epidermophyton	other-disease
floccosum	other-disease
``	O
and	O
``	O
Candida	other-disease
albicans	other-disease
``	O
.	O

In	O
contrast	O
with	O
hyp	other-disease
''	other-disease
er	other-disease
''	other-disease
hidrosis	other-disease
,	O
which	O
is	O
a	O
socially	O
troubling	O
yet	O
often	O
benign	O
condition	O
,	O
the	O
consequences	O
of	O
untreated	O
hypohidrosis	other-disease
include	O
hyperthermia	O
,	O
heat	O
stroke	O
and	O
death	O
.	O

Affected	O
birds	O
tend	O
to	O
appear	O
depressed	O
with	O
reduced	O
appetite	O
,	O
diarrhea	other-disease
,	O
and	O
depigmentation	O
.	O

Alterations	O
of	O
PMP22	other-biologything
gene	other-biologything
expression	O
are	O
associated	O
with	O
a	O
variety	O
of	O
neuropathies	other-disease
,	O
such	O
as	O
Charcot–Marie–Tooth	other-disease
type	other-disease
1A	other-disease
(	O
CMT1A	other-disease
)	O
,	O
Dejerine–Sottas	other-disease
disease	other-disease
,	O
and	O
Hereditary	other-disease
Neuropathy	other-disease
with	other-disease
Liability	other-disease
to	other-disease
Pressure	other-disease
Palsy	other-disease
(	O
HNPP	other-disease
)	O
.	O

Because	O
nitrates	other-chemicalthing
interfere	O
with	O
blood	O
's	O
capacity	O
to	O
carry	O
oxygen	other-chemicalthing
,	O
infants	O
are	O
at	O
high	O
risk	O
of	O
death	O
from	O
blue-baby	other-disease
syndrome	other-disease
,	O
which	O
can	O
occur	O
when	O
there	O
are	O
high	O
nitrate	other-chemicalthing
levels	O
in	O
the	O
blood	O
that	O
are	O
untreated	O
.	O

Mutations	O
of	O
this	O
gene	O
are	O
commonly	O
found	O
in	O
a	O
variety	O
of	O
cancers	O
:	O
in	O
primary	other-disease
hepatocellular	other-disease
carcinoma	other-disease
,	O
colorectal	other-disease
cancer	other-disease
,	O
ovarian	other-disease
carcinoma	other-disease
,	O
breast	other-disease
cancer	other-disease
,	O
lung	other-disease
cancer	other-disease
and	O
glioblastoma	other-disease
.	O

At	O
autopsy	O
pineal	other-disease
hyperplasia	other-disease
was	O
found	O
in	O
all	O
three	O
.	O

Other	O
conditions	O
associated	O
with	O
this	O
condition	O
include	O
acanthosis	other-disease
nigricans	other-disease
,	O
fatty	other-disease
liver	other-disease
,	O
hypertriglyceridemia	other-disease
and	O
polycystic	other-disease
ovary	other-disease
syndrome	other-disease
in	O
women	O
.	O

Blood	O
pressure	O
then	O
spontaneously	O
and	O
rapidly	O
returns	O
to	O
normal	O
,	O
so	O
the	O
period	O
of	O
hypotension	other-disease
and	O
symptoms	O
is	O
short	O
(	O
&	O
lt	O
;	O
30	O
s	O
)	O
.	O

In	O
the	O
older	O
girl	O
the	O
genitalia	O
were	O
large	O
enough	O
at	O
the	O
age	O
of	O
6	O
months	O
to	O
permit	O
vaginal	O
examination	O
for	O
diagnosis	O
of	O
a	O
left	other-disease
ovarian	other-disease
tumor	other-disease
which	O
was	O
removed	O
soon	O
afterward	O
.	O

In	O
McCune-Albright	other-disease
syndrome	other-disease
(	O
MAS	other-disease
)	O
tamoxifen	other-chemicalthing
has	O
been	O
used	O
to	O
treat	O
premature	O
puberty	O
and	O
the	O
consequences	O
of	O
premature	O
puberty	O
.	O

When	O
Mary	person-other
Vierra	person-other
contracted	O
tuberculosis	other-disease
in	O
her	O
youth	O
,	O
she	O
was	O
forced	O
to	O
convalesce	O
at	O
a	O
nearby	O
hospital	O
,	O
often	O
for	O
months	O
at	O
a	O
time	O
during	O
treatment	O
.	O

Besides	O
,	O
safe	O
blood	O
and	O
blood	O
components	O
service	O
,	O
the	O
trust	O
also	O
runs	O
a	O
thalassaemia	other-disease
centre	O
.	O

%	O
-	O
Johnson	person-athlete
is	O
an	O
injury	O
replacement	O
for	O
Joseph	person-artist,author
who	O
suffered	O
a	O
bone	other-disease
bruise	other-disease
in	O
his	O
right	O
knee	O
.	O

Compared	O
to	O
classic	O
PKU	other-disease
patients	O
,	O
patients	O
with	O
``	O
hyperphe	other-disease
``	O
have	O
greater	O
PAH	other-biologything
enzyme	O
activity	O
and	O
are	O
able	O
to	O
tolerate	O
larger	O
amounts	O
of	O
phenylalanine	other-biologything
in	O
their	O
diets	O
.	O

Other	O
studies	O
have	O
also	O
suggested	O
that	O
plantar	other-disease
fasciitis	other-disease
is	O
not	O
due	O
to	O
the	O
inflamed	O
plantar	O
fascia	O
but	O
maybe	O
a	O
tendon	O
injury	O
involving	O
the	O
flexor	O
digitorum	O
brevis	O
muscle	O
located	O
immediately	O
deep	O
to	O
the	O
plantar	O
fascia	O
.	O

Several	O
clinical	O
trials	O
have	O
been	O
performed	O
to	O
assess	O
the	O
safety	O
and	O
effectivity	O
of	O
epigenetic	O
therapy	O
as	O
a	O
pretreatment	O
in	O
cancer	other-disease
therapy	O
.	O

Budd	person-scholar
,	O
on	O
the	O
other	O
hand	O
,	O
is	O
credited	O
with	O
decreasing	O
the	O
incidence	O
of	O
deaths	O
in	O
Bristol	location-GPE
from	O
cholera	other-disease
,	O
from	O
2000	O
(	O
out	O
of	O
a	O
population	O
of	O
140,000	O
)	O
in	O
1849	O
to	O
29	O
in	O
1866	O
.	O

Claustrophobia	other-disease
also	O
plays	O
a	O
great	O
part	O
in	O
special	O
effects	O
.	O

It	O
was	O
found	O
that	O
within	O
this	O
population	O
,	O
there	O
was	O
limited	O
education	O
and	O
even	O
if	O
the	O
Peruvian	location-GPE
men	O
knew	O
their	O
personal	O
risk	O
for	O
the	O
HIV	other-disease
infection	other-disease
,	O
they	O
were	O
not	O
more	O
likely	O
to	O
try	O
and	O
obtain	O
contraception	O
.	O

When	O
controlling	O
for	O
PTSD	other-disease
symptoms	O
and	O
demographic	O
factors	O
,	O
regular	O
cannabis	O
use	O
was	O
still	O
significantly	O
related	O
to	O
sexual	O
trauma	O
.	O

Since	O
many	O
,	O
if	O
not	O
most	O
,	O
anal	other-disease
cancers	other-disease
derive	O
from	O
HPV	other-biologything
infections	O
,	O
and	O
since	O
the	O
HPV	other-biologything
vaccine	O
before	O
exposure	O
to	O
HPV	other-biologything
prevents	O
infection	O
by	O
some	O
strains	O
of	O
the	O
virus	O
and	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
potentially	O
precancerous	O
lesions	O
,	O
scientists	O
surmise	O
that	O
HPV	other-biologything
vaccination	O
may	O
reduce	O
the	O
incidence	O
of	O
anal	other-disease
cancer	other-disease
.	O

Washkansky	person-other
,	O
however	O
,	O
died	O
18	O
days	O
later	O
from	O
pneumonia	other-disease
.	O

He	O
was	O
elected	O
a	O
Fellow	O
of	O
the	O
Royal	organization-education
College	organization-education
of	organization-education
Physicians	organization-education
in	O
1929	O
,	O
delivering	O
the	O
Croonian	event-other
Lecture	event-other
on	O
The	O
Natural	O
History	O
of	O
Bright	other-disease
's	other-disease
Disease	other-disease
in	O
1941	O
.	O

After	O
battling	O
with	O
leukemia	other-disease
for	O
some	O
years	O
,	O
Mansa	person-other
Nettey	person-other
founded	O
the	O
Leukemia	organization-other
Project	organization-other
Foundation	organization-other
in	O
Ghana	location-GPE
.	O

BTG	organization-company
subsequently	O
won	O
approvals	O
for	O
orphan	O
drug	O
status	O
by	O
the	O
Food	organization-government,governmentagency
and	organization-government,governmentagency
Drug	organization-government,governmentagency
Administration	organization-government,governmentagency
for	O
treating	O
alcoholic	O
hepatitis	O
,	O
Turner	other-disease
syndrome	O
,	O
and	O
HIV	other-disease
-induced	O
weight	O
loss	O
.	O

Such	O
mutations	O
and	O
epigenetic	O
alterations	O
can	O
give	O
rise	O
to	O
cancer	O
(	O
see	O
malignant	other-disease
neoplasms	other-disease
)	O
.	O

In	O
2000	O
,	O
a	O
70-year-old	O
man	O
presented	O
with	O
akinetopsia	other-disease
.	O

Two	O
of	O
the	O
group	O
subsequently	O
tested	O
positive	O
for	O
COVID-19	other-disease
and	O
the	O
eight	O
players	O
were	O
put	O
into	O
self-isolation	O
.	O

‌Five	O
years	O
earlier	O
,	O
Claude	person-other
had	O
been	O
introduced	O
to	O
a	O
'	O
Father	person-other
Forget	person-other
'	O
,	O
a	O
former	O
minister	O
of	O
the	O
Reformed	organization-religion
Church	organization-religion
of	organization-religion
France	organization-religion
who	O
claimed	O
to	O
be	O
able	O
to	O
cure	O
her	O
Parkinson	other-disease
's	O
disease	O
through	O
communal	O
prayer	O
.	O

In	O
Egypt	location-GPE
,	O
the	O
number	O
of	O
cases	O
of	O
neonatal	other-disease
tetanus	other-disease
dropped	O
from	O
4,000	O
to	O
fewer	O
than	O
500	O
annually	O
as	O
the	O
result	O
of	O
an	O
immunisation	O
campaign	O
.	O

Usually	O
this	O
hypoglycemia	other-disease
can	O
easily	O
be	O
treated	O
with	O
more	O
frequent	O
feedings	O
or	O
medical	O
doses	O
of	O
glucose	O
.	O

Wakatsuki	person-other
died	O
of	O
Angina	other-disease
pectoris	O
at	O
his	O
summer	O
home	O
in	O
Itō	location-GPE
,	O
Shizuoka	location-GPE
on	O
November	O
20	O
,	O
1949	O
.	O

Sarcoidosis	other-disease
is	O
typically	O
treated	O
with	O
systemic	O
corticosteroids	O
.	O

Oncogenic	O
PKC-iota	other-biologything
can	O
promote	O
melanoma	other-disease
cell	O
invasion	O
by	O
up-regulating	O
PKC-ι	other-biologything
/	O
Par6	other-biologything
pathway	O
during	O
EMT	other-biologything
.	O

In	O
children	O
,	O
hypothyroidism	O
leads	O
to	O
delayed	O
growth	O
and	O
in	O
extreme	O
inborn	O
forms	O
to	O
a	O
syndrome	O
called	O
``	O
cretinism	other-disease
``	O
.	O

X-linked	other-disease
thrombocytopenia	other-disease
is	O
typically	O
diagnosed	O
in	O
infancy	O
.	O

About	O
50	O
%	O
of	O
individuals	O
with	O
Ebstein	other-disease
's	other-disease
anomaly	other-disease
have	O
an	O
associated	O
shunt	O
between	O
the	O
right	O
and	O
left	O
atria	other-biologything
,	O
either	O
an	O
atrial	O
septal	O
defect	O
or	O
a	O
patent	O
foramen	O
ovale	O
.	O

Xerostomia	other-disease
,	O
or	O
a	O
decrease	O
in	O
saliva	O
flow	O
,	O
can	O
be	O
a	O
side	O
effect	O
of	O
many	O
drugs	O
,	O
which	O
,	O
in	O
turn	O
,	O
can	O
lead	O
to	O
the	O
development	O
of	O
taste	O
disturbances	O
such	O
as	O
dysgeusia	O
.	O

The	O
latent	O
phase	O
of	O
syphilis	other-disease
can	O
last	O
many	O
years	O
after	O
which	O
,	O
without	O
treatment	O
,	O
approximately	O
15-40	O
%	O
of	O
people	O
can	O
develop	O
tertiary	O
syphilis	other-disease
.	O

In	O
a	O
revised	O
system	O
of	O
classification	O
adopted	O
by	O
the	organization-other
Scientific	organization-other
and	organization-other
Standardization	organization-other
Committee	organization-other
of	organization-other
the	organization-other
International	organization-other
Society	organization-other
on	organization-other
Thrombosis	organization-other
and	organization-other
Haemostasis	organization-other
,	O
type	other-disease
Ib	other-disease
cases	O
are	O
now	O
designated	O
as	O
type	other-disease
II	other-disease
PE	other-disease
,	O
Pleiotrophic	O
effect	O
.	O

This	O
was	O
the	O
fifth	O
of	O
eight	O
seasons	O
that	O
``	O
League	other-award
Awards	other-award
``	O
,	O
a	O
precursor	O
to	O
the	O
Major	other-disease
League	other-disease
Baseball	other-disease
Most	O
Valuable	O
Player	O
Award	O
(	O
introduced	O
in	O
1931	O
)	O
,	O
were	O
issued	O
.	O

While	O
in	O
some	O
individuals	O
gingivitis	other-disease
never	O
progresses	O
to	O
periodontitis	other-disease
,	O
periodontitis	other-disease
is	O
always	O
preceded	O
by	O
gingivitis	other-disease
.	O

Because	O
Scheie	other-disease
syndrome	O
is	O
an	O
autosomal	O
recessive	O
disorder	O
,	O
affected	O
persons	O
have	O
two	O
nonworking	O
copies	O
of	O
the	O
gene	O
.	O

Recurrent	O
rearrangements	O
of	O
this	O
gene	O
with	O
the	O
Ewing	other-chemicalthing
's	other-chemicalthing
sarcoma	other-chemicalthing
gene	other-chemicalthing
,	O
EWSR1	other-chemicalthing
on	O
chromosome	O
22	O
,	O
or	O
with	O
the	O
TAF15	other-chemicalthing
gene	other-chemicalthing
on	O
chromosome	O
17	O
,	O
or	O
with	O
the	O
TCF3	other-chemicalthing
(	other-chemicalthing
E2A	other-chemicalthing
)	other-chemicalthing
gene	O
on	O
chromosome	O
19	O
,	O
have	O
been	O
observed	O
in	O
acute	O
leukemia	other-disease
.	O

In	O
August	O
2014	O
,	O
she	O
contracted	O
Dengue	other-disease
fever	other-disease
during	O
the	O
2014	O
Dengue	event-other
fever	event-other
outbreak	event-other
.	O

A	O
20th	O
anniversary	O
concert	O
event	O
was	O
held	O
in	O
May	O
1988	O
at	O
the	O
United	organization-other
Nations	organization-other
General	organization-other
Assembly	organization-other
to	O
benefit	O
children	O
with	O
AIDS	other-disease
.	O

She	O
was	O
diagnosed	O
with	O
Asperger	other-disease
Syndrome	other-disease
when	O
she	O
was	O
15	O
.	O

Although	O
7000	O
to	O
8000	O
new	O
cases	O
of	O
testicular	other-disease
cancer	other-disease
occur	O
in	O
the	O
United	location-GPE
States	location-GPE
yearly	O
,	O
only	O
400	O
men	O
are	O
expected	O
to	O
die	O
of	O
the	O
disease	O
.	O

APP	O
is	O
best	O
known	O
as	O
the	O
precursor	O
molecule	O
whose	O
proteolysis	O
generates	O
amyloid	other-biologything
beta	other-biologything
(	O
Aβ	other-biologything
)	O
,	O
a	O
polypeptide	O
containing	O
37	O
to	O
49	O
amino	O
acid	O
residues	O
,	O
whose	O
amyloid	O
fibrillar	O
form	O
is	O
the	O
primary	O
component	O
of	O
amyloid	O
plaques	O
found	O
in	O
the	O
brains	O
of	O
Alzheimer	other-disease
's	O
disease	O
patients	O
.	O

Among	O
the	O
main	O
physical	O
health	O
problems	O
that	O
are	O
life-threatening	O
for	O
men	O
in	O
Australia	location-GPE
are	O
stroke	O
,	O
type	other-disease
2	other-disease
diabetes	other-disease
,	O
chronic	other-disease
lower	other-disease
respiratory	other-disease
disease	other-disease
,	O
blood	other-disease
and	other-disease
lymph	other-disease
cancer	other-disease
,	O
lung	other-disease
cancer	other-disease
,	O
prostate	other-disease
cancer	other-disease
and	O
colorectal	other-disease
cancer	other-disease
with	O
the	O
leading	O
cause	O
of	O
death	O
in	O
males	O
being	O
ischaemic	other-disease
heart	other-disease
disease	other-disease
.	O

``	O
Diseases	art-writtenart
of	art-writtenart
Canaries	art-writtenart
``	O
is	O
a	O
comprehensive	O
work	O
which	O
contains	O
much	O
information	O
on	O
:	O
Anatomy	O
–	O
Feeding	O
–	O
Feeding	O
Experiments	O
–	O
Insects	O
and	O
Parasites	O
–	O
The	O
Moult	O
–	O
Injuries	O
–	O
Septic	other-disease
Fever	other-disease
–	O
Sepsis	other-disease
–	O
Necrosis	other-disease
–	O
Diarrhea	other-disease
–	O
Aspergillosis	other-disease
–	O
Bacteriology	O
–	O
Pathogenic	O
Organisms	O
–	O
Drugs	O
.	O

Dengue	other-disease
fever	other-disease
has	O
become	O
endemic	O
to	O
the	O
republic	O
,	O
cases	O
of	O
malaria	other-disease
,	O
and	O
Zika	other-disease
virus	other-disease
.	O

Beta	other-disease
thalassemia	other-disease
is	O
caused	O
by	O
mutations	O
to	O
or	O
deletions	O
of	O
the	O
HBB	other-biologything
gene	other-biologything
leading	O
to	O
reduced	O
or	O
absent	O
synthesis	O
of	O
the	O
beta	O
chains	O
of	O
hemoglobin	O
that	O
result	O
in	O
variable	O
outcomes	O
ranging	O
from	O
severe	O
anemia	O
to	O
clinically	O
asymptomatic	O
individuals	O
.	O

Haemochromatosis	other-disease
arthropathy	O
includes	O
degenerative	O
osteoarthritis	other-disease
and	O
chondrocalcinosis	other-disease
.	O

They	O
termed	O
it	O
``	O
mycotic	other-disease
pseudotuberculosis	other-disease
``	O
,	O
now	O
known	O
as	O
allergic	O
bronchopulmonary	other-disease
aspergillosis	other-disease
.	O

On	O
July	O
30	O
,	O
2016	O
,	O
Plewa	person-athlete
suffered	O
a	O
stroke	O
following	O
their	O
game	O
against	O
Richmond	organization-sportsteam
Kickers	organization-sportsteam
caused	O
by	O
Protein	other-disease
S	other-disease
deficiency	other-disease
which	O
is	O
a	O
rare	O
blood	O
disorder	O
which	O
can	O
lead	O
to	O
an	O
increased	O
risk	O
of	O
thrombosis	O
.	O

Drug	O
abuse	O
is	O
increasing	O
among	O
street	O
children	O
and	O
rates	O
of	O
HIV/AIDS	other-disease
are	O
increasing	O
due	O
to	O
intravenous	O
drug	O
usage	O
.	O

They	O
often	O
cause	O
an	O
initial	O
flare-up	O
of	O
acne	other-disease
and	O
facial	O
flushing	O
and	O
can	O
cause	O
significant	O
skin	O
irritation	O
.	O

The	O
prison	O
has	O
a	O
Dangerous	other-disease
Severe	other-disease
Personality	other-disease
Disorder	other-disease
(	O
DSPD	other-disease
)	O
unit	O
and	O
a	O
Close	organization-other
Supervision	organization-other
Centre	organization-other
(	O
CSC	O
)	O
.	O

The	O
progressive	O
degeneration	O
of	O
the	O
motor	other-biologything
neurons	other-biologything
in	O
ALS	other-disease
eventually	O
leads	O
to	O
their	O
death	O
.	O

A	O
2001	O
report	O
from	O
the	O
United	organization-other
Nations	organization-other
Office	organization-other
for	organization-other
the	organization-other
Coordination	organization-other
of	organization-other
Humanitarian	organization-other
Affairs	organization-other
(	O
OCHA	organization-other
)	O
noted	O
that	O
the	O
villagers	O
were	O
suffering	O
from	O
waterborne	O
diseases	O
such	O
as	O
Guinea	other-disease
worm	other-disease
,	O
river	other-disease
blindness	other-disease
and	O
cholera	other-disease
,	O
which	O
could	O
be	O
reduced	O
if	O
the	O
people	O
were	O
given	O
the	O
infrastructure	O
and	O
taught	O
how	O
to	O
build	O
good	O
riverbed	O
wells	O
,	O
and	O
were	O
given	O
water	O
and	O
sanitation	O
education	O
.	O

In	O
bladder	other-disease
cancer	other-disease
cells	O
,	O
GM3	other-biologything
show	O
antiproliferative	O
effects	O
.	O

However	O
,	O
its	O
use	O
as	O
a	O
cancer	O
treatment	O
is	O
restricted	O
due	O
to	O
serious	O
side	O
effects	O
such	O
as	O
pulmonary	other-disease
edema	other-disease
.	O

In	O
a	O
person	O
who	O
is	O
compensated	O
,	O
this	O
may	O
show	O
cardiomegaly	other-disease
(	O
visible	O
enlargement	O
of	O
the	O
heart	O
)	O
,	O
quantified	O
as	O
the	O
cardiothoracic	O
ratio	O
(	O
proportion	O
of	O
the	O
heart	O
size	O
to	O
the	O
chest	O
)	O
.	O

This	O
virulence	O
factor	O
induces	O
vomiting	O
and	O
has	O
been	O
associated	O
with	O
food	other-disease
posioning	other-disease
in	O
humans	O
.	O

A	O
number	O
of	O
conditions	O
,	O
such	O
as	O
Parkinson	other-disease
's	other-disease
disease	other-disease
,	O
are	O
thought	O
to	O
trigger	O
sleepwalking	O
in	O
people	O
without	O
a	O
previous	O
history	O
of	O
sleepwalking	O
.	O

This	O
assay	O
is	O
recognized	O
by	O
the	O
Center	organization-other
for	organization-other
Disease	organization-other
Control	organization-other
and	organization-other
Prevention	organization-other
as	O
a	O
special	O
TB	other-disease
blood	O
test	O
with	O
an	O
accuracy	O
of	O
diagnosing	O
active	O
TB	other-disease
&	O
gt	O
;	O
80	O
%	O
.	O

Specifically	O
,	O
common	O
side	O
effects	O
include	O
difficulty	O
becoming	O
aroused	O
,	O
lack	O
of	O
interest	O
in	O
sex	O
,	O
and	O
anorgasmia	other-disease
(	O
trouble	O
achieving	O
orgasm	O
)	O
.	O

Symptoms	O
of	O
floppy	other-disease
infant	other-disease
syndrome	other-disease
and	O
the	O
neonatal	other-disease
benzodiazepine	other-disease
withdrawal	other-disease
syndrome	other-disease
have	O
been	O
reported	O
to	O
persist	O
from	O
hours	O
to	O
months	O
after	O
birth	O
.	O

She	O
served	O
on	O
the	O
American	organization-other
Psychiatric	organization-other
Association	organization-other
DSM-IV	organization-other
Subcommittee	organization-other
on	O
Gender	other-disease
Identity	other-disease
Disorders	other-disease
.	O

It	O
consists	O
of	O
fashioning	O
two	O
orthogonal	O
and	O
deep	O
central	O
grooves	O
in	O
the	O
crystalline	O
lens	O
nucleus	O
,	O
followed	O
by	O
mechanical	O
fracturing	O
of	O
the	O
cataract	other-disease
with	O
the	O
phacoemulsification	O
probe	O
and	O
second	O
instrument	O
.	O

Symptoms	O
of	O
ischemic	other-disease
colitis	other-disease
vary	O
depending	O
on	O
the	O
severity	O
of	O
the	O
ischemia	O
.	O

He	O
seek	O
to	O
improve	O
hypertension	other-disease
control	O
,	O
unhealthy	O
diets	O
and	O
physical	O
inactivity	O
on	O
a	O
national	O
and	O
global	O
scale	O
.	O

According	O
to	O
guidelines	O
,	O
taking	O
aspirin	O
or	O
clopidogrel	O
is	O
recommended	O
to	O
reduce	O
MI	other-disease
,	O
stroke	O
,	O
and	O
other	O
causes	O
of	O
vascular	O
death	O
in	O
people	O
with	O
symptomatic	O
peripheral	O
artery	O
disease	O
.	O

She	O
started	O
learning	O
American	other-language
Sign	other-language
Language	other-language
at	O
17	O
,	O
before	O
she	O
found	O
out	O
she	O
had	O
Ménière	other-disease
's	other-disease
disease	other-disease
,	O
which	O
leads	O
to	O
hearing	O
loss	O
.	O

Without	O
dietary	O
intervention	O
,	O
mild	other-disease
HPA	other-disease
patients	O
have	O
blood	O
Phe	other-biologything
levels	O
higher	O
than	O
those	O
with	O
normal	O
PAH	other-biologything
activity	O
.	O

Reduced	O
HRV	O
has	O
been	O
shown	O
to	O
be	O
a	O
predictor	O
of	O
mortality	O
after	O
myocardial	other-disease
infarction	other-disease
although	O
others	O
have	O
shown	O
that	O
the	O
information	O
in	O
HRV	O
relevant	O
to	O
acute	O
myocardial	O
infarction	O
survival	O
is	O
fully	O
contained	O
in	O
the	O
mean	O
heart	O
rate	O
.	O

This	O
episode	O
is	O
considered	O
one	O
of	O
the	O
later	O
outbreaks	O
of	O
the	O
centuries-long	O
pandemic	O
of	O
bubonic	O
plague	O
that	O
began	O
with	O
the	O
Black	other-disease
Death	other-disease
.	O

Huntington	other-disease
's	other-disease
disease	other-disease
is	O
a	O
neurodegenerative	O
disease	O
and	O
most	O
common	O
inherited	O
cause	O
of	O
chorea	other-disease
.	O

Cyclothymia	other-disease
,	O
known	O
today	O
as	O
cyclothymic	other-disease
disorder	other-disease
,	O
tends	O
to	O
be	O
underdiagnosed	O
due	O
to	O
its	O
low	O
intensity	O
.	O

On	O
March	O
6	O
,	O
a	O
woman	O
from	O
Pinal	location-GPE
County	location-GPE
was	O
diagnosed	O
with	O
COVID-19	other-disease
.	O

HSP90	other-biologything
beta	other-biologything
has	O
been	O
identified	O
as	O
one	O
of	O
the	O
autoantigenic	O
biomarkers	O
and	O
targets	O
involved	O
in	O
human	other-disease
ovarian	other-disease
autoimmune	other-disease
disease	other-disease
leading	O
to	O
ovarian	O
failure	O
and	O
thereby	O
infertility	O
.	O

giardiasis	other-disease
,	O
toxoplasmosis	other-disease
,	O
cryptosporidiosis	other-disease
,	O
trichomoniasis	other-disease
,	O
Chagas	other-disease
disease	other-disease
,	O
leishmaniasis	other-disease
,	O
African	other-disease
trypanosomiasis	other-disease
(	O
sleeping	other-disease
sickness	other-disease
)	O
,	O
``	other-disease
Acanthamoeba	other-disease
''	other-disease
keratitis	other-disease
,	O
and	O
primary	other-disease
amoebic	other-disease
meningoencephalitis	other-disease
(	O
naegleriasis	other-disease
)	O
.	O

Conversely	O
,	O
for	O
intra-abdominal	other-disease
fibromatosis	other-disease
without	O
evidence	O
of	O
FAP	other-disease
extensive	O
surgery	O
may	O
still	O
be	O
required	O
for	O
local	O
symptoms	O
,	O
but	O
the	O
risk	O
of	O
recurrence	O
is	O
low	O
.	O

The	O
disease	O
is	O
restricted	O
to	O
individuals	O
with	O
Down	other-disease
syndrome	other-disease
or	O
genetic	O
changes	O
similar	O
to	O
those	O
in	O
Down	other-disease
syndrome	other-disease
,	O
develops	O
during	O
pregnancy	O
or	O
shortly	O
after	O
birth	O
,	O
and	O
resolves	O
within	O
3	O
months	O
,	O
or	O
in	O
about	O
10	O
%	O
of	O
cases	O
,	O
progresses	O
to	O
acute	other-disease
megakaryoblastic	other-disease
leukemia	other-disease
.	O

Genetic	O
defects	O
involving	O
aquaporin	other-biologything
genes	other-biologything
have	O
been	O
associated	O
with	O
several	O
human	O
diseases	O
including	O
nephrogenic	other-disease
diabetes	other-disease
insipidus	other-disease
and	O
neuromyelitis	other-disease
optica	other-disease
.	O

Although	O
Jenner	person-other
was	O
not	O
the	O
first	O
person	O
to	O
conceive	O
the	O
notion	O
of	O
cowpox	other-disease
protecting	O
against	O
the	O
smallpox	other-disease
virus	O
,	O
his	O
experiment	O
proved	O
the	O
theory	O
.	O

There	O
are	O
criticisms	O
within	O
the	O
scientific	O
community	O
about	O
directing	O
resources	O
to	O
repurposing	O
drugs	O
specifically	O
developed	O
for	O
HIV	other-disease
/	O
AIDS	other-disease
because	O
such	O
drugs	O
are	O
unlikely	O
to	O
be	O
effective	O
against	O
a	O
virus	O
lacking	O
the	O
specific	O
HIV-1	other-disease
protease	O
they	O
target	O
.	O

Underexcretion	O
of	O
uric	O
acid	O
by	O
the	O
kidney	O
is	O
the	O
primary	O
cause	O
of	O
hyperuricemia	other-disease
in	O
about	O
90	O
%	O
of	O
cases	O
,	O
while	O
overproduction	O
is	O
the	O
cause	O
in	O
less	O
than	O
10	O
%	O
.	O

This	O
finding	O
has	O
led	O
to	O
the	O
initiation	O
of	O
AD	O
clinical	O
trials	O
of	O
metal	O
chaperones	O
targeting	O
metal-induced	O
aggregation	O
of	O
beta-amyloid	other-biologything
in	O
AD	O
and	O
of	O
alpha-synuclein	other-biologything
and	O
Lewy	O
bodies	O
in	O
Parkinson	other-disease
disease	O
(	O
being	O
carried	O
out	O
by	O
Alterity	O
Therapeutics	O
,	O
formally	O
Prana	O
Biotechnology	O
,	O
co-founded	O
by	O
Dr	O
.	O
Tanzi	person-scholar
)	O
.	O

In	O
the	O
advanced	O
stages	O
it	O
can	O
result	O
in	O
a	O
coma	other-disease
.	O

By	O
2007	O
,	O
GW501516	O
had	O
completed	O
two	O
phase	O
II	O
clinical	O
studies	O
and	O
other	O
studies	O
relating	O
to	O
obesity	other-disease
,	O
diabetes	other-disease
,	O
dyslipidemia	other-disease
and	O
cardiovascular	other-disease
disease	other-disease
,	O
but	O
GSK	organization-company
abandoned	O
further	O
development	O
of	O
the	O
drug	O
in	O
2007	O
for	O
reasons	O
which	O
were	O
not	O
disclosed	O
at	O
the	O
time	O
.	O

Tuberculin	other-biologything
reaction	other-biologything
or	O
Type	other-disease
1	other-disease
diabetes	other-disease
belong	O
to	O
this	O
category	O
of	O
autoimmunity	O
.	O

Additionally	O
,	O
it	O
has	O
yet	O
to	O
be	O
associated	O
with	O
reducing	O
adverse	O
cardiovascular	O
events	O
including	O
myocardial	other-disease
infarction	other-disease
and	O
stroke	other-disease
,	O
or	O
overall	O
all-cause	O
mortality	O
reduction	O
in	O
clinical	O
trials	O
.	O

Other	O
conditions	O
affecting	O
the	O
trigeminal	O
nerve	O
(	O
V	O
)	O
include	O
trigeminal	other-disease
neuralgia	other-disease
,	O
herpes	other-disease
zoster	other-disease
,	O
sinusitis	other-disease
pain	other-disease
,	O
presence	O
of	O
a	O
dental	other-disease
abscess	other-disease
,	O
and	O
cluster	other-disease
headaches	other-disease
.	O

The	O
risk	O
,	O
however	O
,	O
varies	O
depending	O
on	O
the	O
degree	O
of	O
hyperuricemia	other-disease
.	O

Marinacci	person-scholar
(	O
1960	O
)	O
applied	O
EMG	O
biofeedback	O
to	O
neuromuscular	O
disorders	O
(	O
where	O
proprioception	O
is	O
disrupted	O
)	O
including	O
Bell	other-disease
Palsy	other-disease
(	O
one-sided	O
facial	O
paralysis	O
)	O
,	O
polio	other-disease
,	O
and	O
stroke	O
.	O

This	O
can	O
manifest	O
as	O
a	O
coloboma	other-disease
(	other-disease
hole	other-disease
)	other-disease
in	other-disease
the	other-disease
iris	other-disease
,	O
cataracts	other-disease
,	O
opacity	other-disease
of	other-disease
the	other-disease
cornea	other-disease
(	O
leukoma	other-disease
)	O
,	O
sclerocornea	other-disease
(	O
in	O
which	O
the	O
white	O
of	O
the	O
eye	O
blends	O
into	O
the	O
cornea	O
)	O
,	O
a	O
small	other-disease
cornea	other-disease
(	O
microcornea	other-disease
)	O
and	O
synechia	other-disease
(	O
in	O
which	O
the	O
iris	O
adheres	O
to	O
the	O
cornea	O
or	O
lens	O
)	O
.	O

Additional	O
reviews	O
agree	O
,	O
with	O
studies	O
finding	O
that	O
vaccines	O
are	O
not	O
linked	O
to	O
autism	other-disease
even	O
in	O
high	O
risk	O
populations	O
with	O
autistic	O
siblings	O
.	O

Estimates	O
for	O
the	O
incidence	O
of	O
androgen	other-disease
insensitivity	other-disease
syndrome	other-disease
are	O
based	O
on	O
a	O
relatively	O
small	O
population	O
size	O
,	O
thus	O
are	O
known	O
to	O
be	O
imprecise	O
.	O

Daubert	person-other
and	O
Schuller	person-other
submitted	O
expert	O
evidence	O
of	O
their	O
own	O
that	O
suggested	O
that	O
Bendectin	other-disease
could	O
cause	O
birth	O
defects	O
.	O

Other	O
disorders	O
need	O
to	O
be	O
ruled	O
out	O
before	O
diagnosing	O
major	other-disease
depressive	other-disease
disorder	other-disease
.	O

Many	O
studies	O
have	O
presented	O
evidence	O
for	O
and	O
against	O
association	O
of	O
autism	other-disease
with	O
viral	O
infection	O
after	O
birth	O
.	O

Glaucoma	other-disease
is	O
a	O
type	O
of	O
blindness	O
that	O
begins	O
at	O
the	O
edge	O
of	O
the	O
visual	O
field	O
and	O
progresses	O
inward	O
.	O

The	O
pathophysiology	other-disease
of	other-disease
nephritic	other-disease
syndrome	other-disease
is	O
dependent	O
on	O
the	O
underlying	O
disease	O
process	O
,	O
which	O
can	O
vary	O
depending	O
on	O
what	O
condition	O
the	O
nephritic	other-disease
syndrome	other-disease
is	O
secondary	O
to	O
.	O

Patients	O
with	O
lcSSc	other-disease
commonly	O
induce	O
pulmonary	O
artery	O
hypertension	O
which	O
may	O
result	O
in	O
cor	O
pulmonale	O
(	O
heart	O
failure	O
due	O
to	O
increased	O
pulmonary	O
artery	O
pressure	O
)	O
.	O

Usually	O
both	O
categories	O
are	O
present	O
in	O
chronic	other-disease
diarrhea	other-disease
of	O
infants	O
.	O

Migraine	other-disease
is	O
a	O
complex	O
disease	O
which	O
affects	O
about	O
15	O
%	O
of	O
the	O
population	O
and	O
can	O
be	O
highly	O
disabling	O
.	O

Oligohydramnios	O
can	O
be	O
caused	O
by	O
infection	O
,	O
kidney	O
dysfunction	O
or	O
malformation	O
(	O
since	O
much	O
of	O
the	O
late	O
amniotic	O
fluid	O
volume	O
is	O
urine	O
)	O
,	O
procedures	O
such	O
as	O
chorionic	O
villus	O
sampling	O
(	O
CVS	other-disease
)	O
,	O
and	O
preterm	O
premature	O
rupture	O
of	O
membranes	O
(	O
PPROM	other-disease
)	O
.	O

Bipolar	other-disease
disorder	other-disease
patients	O
with	O
low	O
implicit	O
self-esteem	O
are	O
more	O
defensive	O
.	O

These	O
are	O
:	O
thrombocytopenia	other-disease
,	O
the	O
presence	O
of	O
candidal	other-disease
dermatitis	other-disease
,	O
the	O
use	O
of	O
systemic	other-biologything
steroids	other-biologything
,	O
birth	O
weights	O
of	O
&	O
lt	O
;	O
1,000	O
g	O
,	O
presence	O
of	O
a	O
central	O
catheter	O
,	O
postponing	O
enteral	O
feeding	O
,	O
vaginal	O
delivery	O
,	O
and	O
the	O
amount	O
of	O
time	O
broad-spectrum	other-biologything
antibiotics	other-biologything
were	O
given	O
.	O

Drugs	O
Hitchings	person-other
'	O
team	O
worked	O
on	O
included	O
2,6-diaminopurine	other-biologything
(	O
a	O
compound	O
to	O
treat	O
leukemia	other-disease
)	O
and	O
p-chlorophenoxy-2,4-diaminopyrimidine	other-biologything
(	O
a	O
folic	other-biologything
acid	other-biologything
antagonist	other-biologything
)	O
.	O

It	O
is	O
not	O
definitely	O
established	O
whether	O
they	O
had	O
HACE	other-disease
or	O
acute	O
decompression	O
sickness	O
.	O

Walter	person-other
T.	person-other
Bailey	person-other
died	O
on	O
February	O
21	O
,	O
1941	O
from	O
pneumonia	other-disease
and	O
complications	O
caused	O
by	O
heart	other-disease
disease	other-disease
.	O

The	O
short-term	O
effects	O
are	O
explained	O
by	O
a	O
hypothesis	O
that	O
states	O
that	O
depression	other-disease
is	O
acutely	O
brought	O
on	O
by	O
an	O
immediate	O
decrease	O
in	O
catecholamines	other-biologything
in	O
the	O
brain	O
.	O

Hypoglycemia	other-disease
is	O
also	O
found	O
in	O
many	O
people	O
with	O
hypothermia	other-disease
,	O
as	O
hypothermia	other-disease
may	O
be	O
a	O
result	O
of	O
hypoglycemia	other-disease
.	O

While	O
some	O
feel	O
the	O
diagnosis	O
of	O
fibromyalgia	other-disease
may	O
negatively	O
affect	O
a	O
person	O
,	O
other	O
research	O
finds	O
it	O
to	O
be	O
beneficial	O
.	O

Myalgia	other-disease
(	O
muscular	O
pain	O
)	O
and	O
arthralgia	other-disease
(	O
joint	O
pain	O
)	O
are	O
rare	O
side	O
effects	O
.	O

Hepatic	other-disease
encephalopathy	other-disease
(	O
HE	other-disease
)	O
is	O
an	O
altered	O
level	O
of	O
consciousness	O
as	O
a	O
result	O
of	O
liver	O
failure	O
.	O

There	O
is	O
an	O
association	O
with	O
Pendred	other-disease
syndrome	other-disease
and	O
incomplete	O
cochlear	O
partition	O
(	O
so	O
called	O
``	O
Mondini	O
dysplasia	O
''	O
)	O
.	O

The	O
addition	O
of	O
GM3	other-biologything
to	O
bladder	other-disease
cancer	other-disease
cells	O
also	O
decreases	O
their	O
cell	O
adhesion	O
and	O
inhibits	O
tumor	O
growth	O
.	O

Mesangial	other-disease
proliferative	other-disease
glomerulonephritis	other-disease
is	O
a	O
form	O
of	O
glomerulonephritis	other-disease
associated	O
primarily	O
with	O
the	O
mesangium	O
.	O

The	location-GPE
United	location-GPE
States	location-GPE
has	O
the	O
highest	O
mortality	O
rate	O
among	O
patients	O
with	O
ESRD	other-disease
.	O

Type	other-disease
2	other-disease
(	O
Dunnigan	O
Variety	O
,	O
FPL2	other-disease
)	O
is	O
the	O
most	O
common	O
form	O
and	O
is	O
due	O
to	O
mutations	O
in	O
the	O
LMNA	other-biologything
gene	other-biologything
.	O

Additionally	O
,	O
they	O
may	O
be	O
suffering	O
from	O
penile	other-disease
dysmorphophobia	other-disease
.	O

Spasm	other-disease
means	O
``	O
uncontrolled	O
muscle	O
contraction	O
''	O
.	O

Many	O
neurodegenerative	other-disease
diseases	other-disease
–	O
including	O
amyotrophic	other-disease
lateral	other-disease
sclerosis	other-disease
,	O
multiple	other-disease
sclerosis	other-disease
,	O
Parkinson	other-disease
's	other-disease
disease	other-disease
,	O
Alzheimer	other-disease
's	other-disease
disease	other-disease
,	O
Huntington	other-disease
's	other-disease
disease	other-disease
,	O
and	O
prion	other-disease
diseases	other-disease
–	O
occur	O
as	O
a	O
result	O
of	O
neurodegenerative	O
processes	O
.	O

After	O
a	O
sleepover	O
at	O
Milhouse	person-other
's	O
,	O
Milhouse	person-other
,	O
Nelson	person-other
,	O
and	O
Bart	person-other
find	O
themselves	O
in	O
a	O
cell	O
,	O
trapped	O
by	O
Lisa	person-other
,	O
suffering	O
from	O
dissociative	other-disease
identity	other-disease
disorder	other-disease
(	O
similar	O
to	O
James	person-actor
McAvoy	person-actor
's	O
character	O
from	O
``	O
Split	art-film
``	O
)	O
,	O
then	O
closes	O
them	O
in	O
again	O
after	O
they	O
do	O
not	O
ask	O
for	O
an	O
encore	O
on	O
her	O
performance	O
.	O

Gangrene	other-disease
is	O
caused	O
by	O
a	O
critically	O
insufficient	O
blood	O
supply	O
(	O
e.g.	O
,	O
peripheral	other-disease
vascular	other-disease
disease	other-disease
)	O
or	O
infection	O
.	O

Persons	O
with	O
self-limiting	other-disease
infection	other-disease
clear	O
the	O
infection	O
spontaneously	O
within	O
weeks	O
to	O
months	O
.	O

Thyroid	other-disease
cancer	other-disease
arising	O
in	O
the	O
background	O
of	O
radiation	O
is	O
often	O
multifocal	O
with	O
a	O
high	O
incidence	O
of	O
lymph	O
node	O
metastasis	O
and	O
has	O
a	O
poor	O
prognosis	O
.	O

This	O
concept	O
was	O
exemplified	O
in	O
2007	O
when	O
a	O
California	location-GPE
woman	O
died	O
of	O
water	other-disease
intoxication	other-disease
in	O
a	O
contest	O
sanctioned	O
by	O
a	O
radio	O
station	O
.	O

Tennis	other-disease
elbow	other-disease
or	O
lateral	other-disease
epicondylitis	other-disease
is	O
a	O
chronic	O
or	O
an	O
acute	O
inflammation	O
of	O
the	O
tendons	O
that	O
arise	O
from	O
the	O
outer	O
part	O
of	O
the	O
elbow	O
.	O

Copps	person-other
continued	O
as	O
mayor	O
until	O
1976	O
when	O
he	O
was	O
forced	O
to	O
retire	O
following	O
a	O
heart	other-disease
attack	other-disease
while	O
running	O
in	O
the	O
Around	event-sportsevent
the	event-sportsevent
Bay	event-sportsevent
Road	event-sportsevent
Race	event-sportsevent
.	O

Clomifene	other-chemicalthing
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
malignant	other-disease
melanomas	other-disease
and	O
thyroid	other-disease
cancer	other-disease
.	O

He	O
died	O
on	O
March	O
17	O
,	O
2020	O
at	O
his	O
home	O
in	O
Winston-Salem	location-GPE
,	O
North	location-GPE
Carolina	location-GPE
of	O
kidney	other-disease
failure	other-disease
.	O

In	O
common	O
forms	O
of	O
MTHFR	other-disease
deficiency	other-disease
,	O
elevated	O
plasma	other-biologything
homocysteine	other-biologything
levels	O
have	O
sometimes	O
been	O
treated	O
with	O
Vitamin	product-other
B12	product-other
and	O
low	O
doses	O
of	O
folic	product-other
acid	product-other
.	O

This	O
contributes	O
to	O
the	O
urinary	O
incontinence	O
seen	O
with	O
NPH	other-disease
.	O

At	O
the	O
time	O
it	O
was	O
proposed	O
,	O
Da	other-disease
Costa	other-disease
's	other-disease
syndrome	other-disease
was	O
seen	O
as	O
a	O
very	O
desirable	O
physiological	O
explanation	O
for	O
``	O
soldier	O
's	O
heart	O
''	O
.	O

Rheumatic	other-disease
fever	other-disease
does	O
not	O
appear	O
to	O
be	O
related	O
.	O

Risk	O
factors	O
for	O
cardiomegaly	O
include	O
a	O
family	O
history	O
of	O
heart	other-disease
disease	other-disease
,	O
diabetes	other-disease
,	O
obesity	other-disease
,	O
hypertension	other-disease
,	O
history	O
of	O
alcohol	O
or	O
drug	O
abuse	O
,	O
the	O
lifestyle	O
that	O
consists	O
of	O
little	O
or	O
no	O
exercise	O
.	O

For	O
example	O
,	O
in	O
cases	O
of	O
hypoalbuminemia	other-disease
the	O
calculated	O
value	O
of	O
the	O
anion	O
gap	O
should	O
be	O
increased	O
by	O
2.3	O
to	O
2.5	O
mEq/L	O
per	O
each	O
1	O
g/dL	O
decrease	O
in	O
serum	other-biologything
albumin	other-biologything
concentration	O
(	O
refer	O
to	O
Sample	O
calculations	O
,	O
below	O
)	O
.	O

Some	O
people	O
with	O
sleep	other-disease
apnea	other-disease
are	O
unaware	O
they	O
have	O
the	O
condition	O
.	O

It	O
is	O
used	O
to	O
prevent	O
and	O
treat	O
scurvy	other-disease
.	O

When	O
Jane	person-artist,author
Winiberg	person-artist,author
saw	O
a	O
progeria	other-disease
television	O
special	O
,	O
she	O
and	O
Mark	person-artist,author
Street	person-artist,author
wrote	O
a	O
song	O
about	O
Okines	person-other
and	O
other	O
children	O
.	O

A	O
characteristic	O
feature	O
of	O
Stickler	other-disease
syndrome	O
is	O
a	O
somewhat	O
flattened	O
facial	O
appearance	O
.	O

At	O
the	O
beginning	O
of	O
the	O
AIDS	other-disease
epidemic	O
in	O
the	O
early	O
1980s	O
,	O
cyclosporiasis	other-disease
was	O
identified	O
as	O
one	O
of	O
the	O
most	O
important	O
opportunistic	O
infections	O
among	O
AIDS	other-disease
patients	O
.	O

Talley	person-scholar
also	O
has	O
a	O
strong	O
interest	O
in	O
gastrointestinal	other-disease
complications	other-disease
in	O
diabetes	other-disease
.	O